4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000899243-18-002040
Chief Financial Officer acquired 13,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Regnante Keith · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-23 | Grant or award : show line 1 in the form | +13,000 | 17,300 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-01-23 | Grant or award : show line 2 in the form Share Option (right to buy) | +26,000 | $40.05 | 2028-01-23 | 26,000 | 26,000 | D |
Loading xslF345X03/doc4.xml…